GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kexing Biopharm Co 688136.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

15.30

-1.48%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥1.54bn

FY2017FY2025

Net income

CN¥159.4m

FY2017FY2025

Free cash flow

CN¥2.4m

FY2017FY2025

Shareholders' equity

CN¥1.75bn

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueCN¥1.54bnCN¥1.41bnCN¥1.26bnCN¥1.32bnCN¥1.29bnCN¥1.22bnCN¥1.19bnCN¥890.6mCN¥615.8m
Research and developmentCN¥199.6mCN¥168.1mCN¥344.8mCN¥193.3mCN¥123.0mCN¥60.1mCN¥46.2mCN¥42.7mCN¥32.3m
Operating incomeCN¥171.8mCN¥63.2m−CN¥225.6m−CN¥117.2mCN¥98.0mCN¥159.8mCN¥189.0mCN¥121.3mCN¥89.3m
Net incomeCN¥159.4mCN¥31.5m−CN¥190.3m−CN¥90.3mCN¥96.5mCN¥139.1mCN¥159.8mCN¥94.2mCN¥59.4m
Diluted earnings per share0.830.15-1.00-0.440.500.911.060.490.31

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsCN¥3.53bnCN¥3.16bnCN¥3.03bnCN¥3.16bnCN¥2.83bnCN¥2.37bnCN¥1.18bnCN¥854.3mCN¥743.2m
Cash and short-term investments—CN¥554.6mCN¥568.8mCN¥785.4mCN¥877.6mCN¥1.10bnCN¥151.0mCN¥55.2mCN¥65.9m
Total liabilitiesCN¥1.78bnCN¥1.52bnCN¥1.40bnCN¥1.35bnCN¥918.3mCN¥536.5mCN¥483.7mCN¥359.9mCN¥531.0m
DebtCN¥727.7mCN¥895.1mCN¥1.12bnCN¥1.04bnCN¥601.3mCN¥315.7mCN¥236.6mCN¥105.4mCN¥105.2m
Shareholders' equityCN¥1.75bnCN¥1.63bnCN¥1.63bnCN¥1.81bnCN¥1.91bnCN¥1.83bnCN¥696.3mCN¥494.5mCN¥212.2m
Shares outstanding191m214m189m203m193m152m150m191m191m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operationsCN¥86.0mCN¥106.7m−CN¥87.1m−CN¥85.9mCN¥94.0mCN¥105.9mCN¥5.3mCN¥63.4mCN¥64.8m
Capital spending−CN¥83.6m−CN¥94.0m−CN¥191.2m−CN¥399.2m−CN¥372.0m−CN¥189.0m−CN¥53.6m−CN¥40.2m−CN¥55.7m
Free cash flowCN¥2.4mCN¥12.7m−CN¥278.3m−CN¥485.1m−CN¥278.0m−CN¥83.0m−CN¥48.3mCN¥23.2mCN¥9.1m
Dividends paid−CN¥57.4m−CN¥43.6m−CN¥45.4m−CN¥19.9m−CN¥15.9m−CN¥10.9m−CN¥7.0m−CN¥9.7m−CN¥48.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥326.6mCN¥280.5mCN¥393.5mCN¥447.2mCN¥346.9mCN¥353.6mCN¥368.7mCN¥278.4m
Operating income−CN¥65.9m−CN¥1.2mCN¥54.2mCN¥31.5mCN¥62.5mCN¥34.1mCN¥7.5mCN¥8.0m
Net incomeCN¥151.9m−CN¥17.9mCN¥48.2mCN¥30.9mCN¥54.8mCN¥25.6mCN¥14.3mCN¥5.3m
Diluted earnings per share0.79-0.090.250.160.290.130.070.02
Cash from operations———−CN¥32.0mCN¥4.0mCN¥25.0m—CN¥89.0m
Capital spending−CN¥23.0m−CN¥13.0m−CN¥32.0m−CN¥20.0m−CN¥21.0m−CN¥8.0m−CN¥26.0m−CN¥16.0m
Free cash flow———−CN¥52.0m−CN¥17.0mCN¥17.0m—CN¥73.0m
Total assetsCN¥3.71bnCN¥3.49bnCN¥3.53bnCN¥3.41bnCN¥3.32bnCN¥3.19bnCN¥3.16bnCN¥3.00bn
Cash and short-term investments———CN¥612.8mCN¥621.0mCN¥576.3mCN¥554.6mCN¥468.2m
DebtCN¥675.0mCN¥685.1mCN¥727.7mCN¥746.1mCN¥982.3mCN¥888.1mCN¥880.3mCN¥806.2m
Shareholders' equityCN¥1.84bnCN¥1.73bnCN¥1.75bnCN¥1.71bnCN¥1.68bnCN¥1.66bnCN¥1.63bnCN¥1.62bn

Financial ratios

Data as of 13 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin11.0%7.3%-17.4%-8.4%8.4%14.4%
Net margin10.3%2.2%-15.1%-6.9%7.5%11.4%
Return on equity9.1%1.9%-11.7%-5.0%5.0%7.6%
Return on assets4.5%1.0%-6.3%-2.9%3.4%5.9%
Free cash flow yield4.0%4.3%2.5%7.0%11.0%8.8%
Revenue growth9.5%11.7%-4.3%2.4%5.3%2.5%
Earnings growth406.5%-116.5%110.7%-193.6%-30.7%-12.9%
Current ratio1.57x1.45x1.69x2.62x2.42x3.73x
Debt to equity0.42x0.54x0.50x0.56x0.28x0.16x
Equity ratio49.6%51.7%53.6%57.3%67.5%77.3%
Interest coverage4.04x2.26x-5.32x-3.77x8.61x10.42x
R&D as a share of sales12.9%11.9%27.4%14.7%9.6%4.9%
Buybacks as a share of market value10.8%-13.2%6.7%-5.2%-26.7%-1.5%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.4%4.8%—
Operating income—1.5%—
Net income—2.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings38.0148.9-20.1-48.256.544.7
Price to sales3.93.33.03.34.25.1

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 12 Jun 2025.

FY2025FY2022FY2021
Paid in the year0.080.100.08

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.